Baseline IGFBP - 3 as the Key Element to Predict Growth Response to Growth Hormone and IGF - 1 Therapy in Subjects with Non - GH Deficient Short Stature and IGF

Baseline IGFBP - 3 as the Key Element to Predict Growth Response to Growth Hormone and IGF - 1 Therapy in Subjects with Non - GH Deficient Short Stature and IGF - 1 Deficiency

Published:2018-05-21 Issue:3 Volume:16 Page:
ISSN:1726-913X
Container-title:International Journal of Endocrinology and Metabolism
language:
Short-container-title:Int J Endocrinol Metab

Author:

Perez-Colon Sheila,Lazareva Oksana,Purushothaman Radhika,Malik Shahid,Ten Svetlana,Bhangoo Amrit

Publisher

Briefland

Subject

Endocrinology, Diabetes and Metabolism

Reference34 articles.

1. Insulin Growth Factor-Based Dosing of Growth Hormone Therapy in Children: A Randomized, Controlled Study

2. Height Velocity Targets from the National Cooperative Growth Study for First-Year Growth Hormone Responses in Short Children

3. Should We Treat Children with Idiopathic Short Stature?

4. Mutations of the Growth Hormone Receptor in Children with Idiopathic Short Stature

5. Growth Hormone Receptor Mutations in Children with Idiopathic Short Stature1

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Alterations in Stem Cell Populations in IGF-1 Deficient Pediatric Patients Subjected to Mecasermin (Increlex) Treatment;Stem Cell Reviews and Reports;2022-10-21

2. Investigating whether serum IGF-1 and IGFBP-3 levels reflect the height outcome in prepubertal children upon rhGH therapy: LG growth study database;PLOS ONE;2021-11-01

3. Efficacy and safety of fermented oyster extract for height of children with short stature: A randomized placebo-controlled trial;Integrative Medicine Research;2021-06

4. Malnutrition in children associated with low growth hormone (Gh) Levels;Gaceta Sanitaria;2021